Global Active Pharmaceutical Ingredients (API) Market Growth 2020-2025


According to this study, over the next five years the Active Pharmaceutical Ingredients (API) market will register a 6.8% CAGR in terms of revenue, the global market size will reach $ 80530 million by 2025, from $ 61840 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Active Pharmaceutical Ingredients (API) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Active Pharmaceutical Ingredients (API) market by type, application, key manufacturers and key regions and countries.

This study considers the Active Pharmaceutical Ingredients (API) value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
    Synthetic APIs
    Biotech APIs

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
    CNS
    Cardiovascular
    Genitourinary/Hormonal Drugs
    Respiratory
    Rheumatology
    Diabetes
    Oncology
    Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
    Teva
    Hisun Pharmaceutical
    Mylan
    Aurobindo Pharma
    Aspen
    DSM
    Pfizer
    Novartis
    Huahai Pharmaceutical
    BASF
    NCPC
    Shandong Xinhua Pharmaceutical
    AbbVie
    Sun Pharmaceutical Industries
    Zhejiang NHU
    Dr. Reddy’s Laboratories
    Harbin Pharmaceutical
    Bayer
    Zhejiang Medicine
    Northeast Pharm
    LKPC

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
    To study and analyze the global Active Pharmaceutical Ingredients (API) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
    To understand the structure of Active Pharmaceutical Ingredients (API) market by identifying its various subsegments.
    Focuses on the key global Active Pharmaceutical Ingredients (API) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Active Pharmaceutical Ingredients (API) with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Active Pharmaceutical Ingredients (API) submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Research Objectives
    1.3 Years Considered
    1.4 Market Research Methodology
    1.5 Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Active Pharmaceutical Ingredients (API) Consumption 2015-2025
        2.1.2 Active Pharmaceutical Ingredients (API) Consumption CAGR by Region
    2.2 Active Pharmaceutical Ingredients (API) Segment by Type
        2.2.1 Synthetic APIs
        2.2.2 Biotech APIs
    2.3 Active Pharmaceutical Ingredients (API) Consumption by Type
        2.3.1 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2015-2020)
        2.3.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Type (2015-2020)
        2.3.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Type (2015-2020)
    2.4 Active Pharmaceutical Ingredients (API) Segment by Application
        2.4.1 CNS
        2.4.2 Cardiovascular
        2.4.3 Genitourinary/Hormonal Drugs
        2.4.4 Respiratory
        2.4.5 Rheumatology
        2.4.6 Diabetes
        2.4.7 Oncology
        2.4.8 Others
    2.5 Active Pharmaceutical Ingredients (API) Consumption by Application
        2.5.1 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2015-2020)
        2.5.2 Global Active Pharmaceutical Ingredients (API) Value and Market Share by Type (2015-2020)
        2.5.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Type (2015-2020)

3 Global Active Pharmaceutical Ingredients (API) by Company
    3.1 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Company
        3.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Company (2018-2020)
        3.1.2 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2018-2020)
    3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Company
        3.2.1 Global Active Pharmaceutical Ingredients (API) Revenue by Company (2018-2020)
        3.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Company (2018-2020)
    3.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Company
    3.4 Global Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution, Sales Area, Type by Company
        3.4.1 Global Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution and Sales Area by Company
        3.4.2 Players Active Pharmaceutical Ingredients (API) Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 Active Pharmaceutical Ingredients (API) by Regions
    4.1 Active Pharmaceutical Ingredients (API) by Regions
    4.2 Americas Active Pharmaceutical Ingredients (API) Consumption Growth
    4.3 APAC Active Pharmaceutical Ingredients (API) Consumption Growth
    4.4 Europe Active Pharmaceutical Ingredients (API) Consumption Growth
    4.5 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Growth

5 Americas
    5.1 Americas Active Pharmaceutical Ingredients (API) Consumption by Countries
        5.1.1 Americas Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020)
        5.1.2 Americas Active Pharmaceutical Ingredients (API) Value by Countries (2015-2020)
    5.2 Americas Active Pharmaceutical Ingredients (API) Consumption by Type
    5.3 Americas Active Pharmaceutical Ingredients (API) Consumption by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
    5.8 Key Economic Indicators of Few Americas Countries

6 APAC
    6.1 APAC Active Pharmaceutical Ingredients (API) Consumption by Regions
        6.1.1 APAC Active Pharmaceutical Ingredients (API) Consumption by Regions (2015-2020)
        6.1.2 APAC Active Pharmaceutical Ingredients (API) Value by Regions (2015-2020)
    6.2 APAC Active Pharmaceutical Ingredients (API) Consumption by Type
    6.3 APAC Active Pharmaceutical Ingredients (API) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
    7.1 Europe Active Pharmaceutical Ingredients (API) by Countries
        7.1.1 Europe Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020)
        7.1.2 Europe Active Pharmaceutical Ingredients (API) Value by Countries (2015-2020)
    7.2 Europe Active Pharmaceutical Ingredients (API) Consumption by Type
    7.3 Europe Active Pharmaceutical Ingredients (API) Consumption by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
    7.9 Spain
    7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
    8.1 Middle East & Africa Active Pharmaceutical Ingredients (API) by Countries
        8.1.1 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020)
        8.1.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Value by Countries (2015-2020)
    8.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Type
    8.3 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Marketing, Distributors and Customer
    10.1 Sales Channel
        10.1.1 Direct Channels
        10.1.2 Indirect Channels
    10.2 Active Pharmaceutical Ingredients (API) Distributors
    10.3 Active Pharmaceutical Ingredients (API) Customer

11 Global Active Pharmaceutical Ingredients (API) Market Forecast
    11.1 Global Active Pharmaceutical Ingredients (API) Consumption Forecast (2021-2025)
    11.2 Global Active Pharmaceutical Ingredients (API) Forecast by Regions
        11.2.1 Global Active Pharmaceutical Ingredients (API) Forecast by Regions (2021-2025)
        11.2.2 Global Active Pharmaceutical Ingredients (API) Value Forecast by Regions (2021-2025)
        11.2.3 Americas Consumption Forecast
        11.2.4 APAC Consumption Forecast
        11.2.5 Europe Consumption Forecast
        11.2.6 Middle East & Africa Consumption Forecast
    11.3 Americas Forecast by Countries
        11.3.1 United States Market Forecast
        11.3.2 Canada Market Forecast
        11.3.3 Mexico Market Forecast
        11.3.4 Brazil Market Forecast
   11.4 APAC Forecast by Countries
        11.4.1 China Market Forecast
        11.4.2 Japan Market Forecast
        11.4.3 Korea Market Forecast
        11.4.4 Southeast Asia Market Forecast
        11.4.5 India Market Forecast
        11.4.6 Australia Market Forecast
    11.5 Europe Forecast by Countries
        11.5.1 Germany Market Forecast
        11.5.2 France Market Forecast
        11.5.3 UK Market Forecast
        11.5.4 Italy Market Forecast
        11.5.5 Russia Market Forecast
        11.5.6 Spain Market Forecast
    11.6 Middle East & Africa Forecast by Countries
        11.6.1 Egypt Market Forecast
        11.6.2 South Africa Market Forecast
        11.6.3 Israel Market Forecast
        11.6.4 Turkey Market Forecast
        11.6.5 GCC Countries Market Forecast
    11.7 Global Active Pharmaceutical Ingredients (API) Forecast by Type
    11.8 Global Active Pharmaceutical Ingredients (API) Forecast by Application

12 Key Players Analysis
    12.1 Teva
        12.1.1 Company Information
        12.1.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.1.3 Teva Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.1.4 Main Business Overview
        12.1.5 Teva Latest Developments
    12.2 Hisun Pharmaceutical
        12.2.1 Company Information
        12.2.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.2.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.2.4 Main Business Overview
        12.2.5 Hisun Pharmaceutical Latest Developments
    12.3 Mylan
        12.3.1 Company Information
        12.3.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.3.3 Mylan Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.3.4 Main Business Overview
        12.3.5 Mylan Latest Developments
    12.4 Aurobindo Pharma
        12.4.1 Company Information
        12.4.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.4.4 Main Business Overview
        12.4.5 Aurobindo Pharma Latest Developments
    12.5 Aspen
        12.5.1 Company Information
        12.5.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.5.4 Main Business Overview
        12.5.5 Aspen Latest Developments
    12.6 DSM
        12.6.1 Company Information
        12.6.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.6.3 DSM Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.6.4 Main Business Overview
        12.6.5 DSM Latest Developments
    12.7 Pfizer
        12.7.1 Company Information
        12.7.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.7.3 Pfizer Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.7.4 Main Business Overview
        12.7.5 Pfizer Latest Developments
    12.8 Novartis
        12.8.1 Company Information
        12.8.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.8.3 Novartis Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.8.4 Main Business Overview
        12.8.5 Novartis Latest Developments
    12.9 Huahai Pharmaceutical
        12.9.1 Company Information
        12.9.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.9.4 Main Business Overview
        12.9.5 Huahai Pharmaceutical Latest Developments
    12.10 BASF
        12.10.1 Company Information
        12.10.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.10.3 BASF Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.10.4 Main Business Overview
        12.10.5 BASF Latest Developments
    12.11 NCPC
        12.11.1 Company Information
        12.11.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.11.3 NCPC Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.11.4 Main Business Overview
        12.11.5 NCPC Latest Developments
    12.12 Shandong Xinhua Pharmaceutical
        12.12.1 Company Information
        12.12.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.12.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.12.4 Main Business Overview
        12.12.5 Shandong Xinhua Pharmaceutical Latest Developments
    12.13 AbbVie
        12.13.1 Company Information
        12.13.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.13.3 AbbVie Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.13.4 Main Business Overview
        12.13.5 AbbVie Latest Developments
    12.14 Sun Pharmaceutical Industries
        12.14.1 Company Information
        12.14.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.14.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.14.4 Main Business Overview
        12.14.5 Sun Pharmaceutical Industries Latest Developments
    12.15 Zhejiang NHU
        12.15.1 Company Information
        12.15.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.15.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.15.4 Main Business Overview
        12.15.5 Zhejiang NHU Latest Developments
    12.16 Dr. Reddy’s Laboratories
        12.16.1 Company Information
        12.16.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.16.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.16.4 Main Business Overview
        12.16.5 Dr. Reddy’s Laboratories Latest Developments
    12.17 Harbin Pharmaceutical
        12.17.1 Company Information
        12.17.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.17.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.17.4 Main Business Overview
        12.17.5 Harbin Pharmaceutical Latest Developments
    12.18 Bayer
        12.18.1 Company Information
        12.18.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.18.3 Bayer Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.18.4 Main Business Overview
        12.18.5 Bayer Latest Developments
    12.19 Zhejiang Medicine
        12.19.1 Company Information
        12.19.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.19.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.19.4 Main Business Overview
        12.19.5 Zhejiang Medicine Latest Developments
    12.20 Northeast Pharm
        12.20.1 Company Information
        12.20.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.20.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.20.4 Main Business Overview
        12.20.5 Northeast Pharm Latest Developments
    12.21 LKPC
        12.21.1 Company Information
        12.21.2 Active Pharmaceutical Ingredients (API) Product Offered
        12.21.3 LKPC Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.21.4 Main Business Overview
        12.21.5 LKPC Latest Developments

13 Research Findings and Conclusion

List of Tables Table 1. Research Methodology Table 2. Data Source Table 3. Active Pharmaceutical Ingredients (API) Consumption CAGR by Region 2015-2025 ($ Millions) Table 4. Major Players of Synthetic APIs Table 5. Major Players of Biotech APIs Table 6. Global Consumption Sales by Type (2015-2020) Table 7. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2015-2020) Table 8. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2015-2020) ($ million) Table 9. Global Active Pharmaceutical Ingredients (API) Value Market Share by Type (2015-2020) ($ Millions) Table 10. Global Active Pharmaceutical Ingredients (API) Sale Price by Type (2015-2020) Table 11. Global Consumption Sales by Application (2015-2020) Table 12. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020) Table 13. Global Active Pharmaceutical Ingredients (API) Value by Application (2015-2020) Table 14. Global Active Pharmaceutical Ingredients (API) Value Market Share by Application (2015-2020) Table 15. Global Active Pharmaceutical Ingredients (API) Sale Price by Application (2015-2020) Table 16. Global Active Pharmaceutical Ingredients (API) Sales by Company (2017-2019) (K MT) Table 17. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2017-2019) Table 18. Global Active Pharmaceutical Ingredients (API) Revenue by Company (2017-2019) ($ Millions) Table 19. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Company (2017-2019) Table 20. Global Active Pharmaceutical Ingredients (API) Sale Price by Company (2017-2019) Table 21. Global Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution and Sales Area by Manufacturers Table 22. Players Active Pharmaceutical Ingredients (API) Products Offered Table 23. Active Pharmaceutical Ingredients (API) Concentration Ratio (CR3, CR5 and CR10) (2017-2019) Table 24. Global Active Pharmaceutical Ingredients (API) Consumption by Regions 2015-2020 (K MT) Table 25. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Regions 2015-2020 Table 26. Global Active Pharmaceutical Ingredients (API) Value by Regions 2015-2020 ($ Millions) Table 27. Global Active Pharmaceutical Ingredients (API) Value Market Share by Regions 2015-2020 Table 28. Americas Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT) Table 29. Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries (2015-2020) Table 30. Americas Active Pharmaceutical Ingredients (API) Value by Countries (2015-2020) ($ Millions) Table 31. Americas Active Pharmaceutical Ingredients (API) Value Market Share by Countries (2015-2020) Table 32. Americas Active Pharmaceutical Ingredients (API) Consumption by Type (2015-2020) (K MT) Table 33. Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2015-2020) Table 34. Americas Active Pharmaceutical Ingredients (API) Consumption by Application (2015-2020) (K MT) Table 35. Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020) Table 36. APAC Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT) Table 37. APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries (2015-2020) Table 38. APAC Active Pharmaceutical Ingredients (API) Value by Regions (2015-2020) ($ Millions) Table 39. APAC Active Pharmaceutical Ingredients (API) Value Market Share by Regions (2015-2020) Table 40. APAC Active Pharmaceutical Ingredients (API) Consumption by Type (2015-2020) (K MT) Table 41. APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2015-2020) Table 42. APAC Active Pharmaceutical Ingredients (API) Consumption by Application (2015-2020) (K MT) Table 43. APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020) Table 44. Europe Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT) Table 45. Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries (2015-2020) Table 46. Europe Active Pharmaceutical Ingredients (API) Value by Countries (2015-2020) ($ Millions) Table 47. Europe Active Pharmaceutical Ingredients (API) Value Market Share by Countries (2015-2020) Table 48. Europe Active Pharmaceutical Ingredients (API) Consumption by Type (2015-2020) (K MT) Table 49. Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2015-2020) Table 50. Europe Active Pharmaceutical Ingredients (API) Consumption by Application (2015-2020) (K MT) Table 51. Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020) Table 52. Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT) Table 53. Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries (2015-2020) Table 54. Middle East & Africa Active Pharmaceutical Ingredients (API) Value by Countries (2015-2020) ($ Millions) Table 55. Middle East & Africa Active Pharmaceutical Ingredients (API) Value Market Share by Countries (2015-2020) Table 56. Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Type (2015-2020) (K MT) Table 57. Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2015-2020) Table 58. Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Application (2015-2020) (K MT) Table 59. Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020) Table 60. Active Pharmaceutical Ingredients (API) Distributors List Table 61. Active Pharmaceutical Ingredients (API) Customer List Table 62. Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Countries (2021-2025) (K MT) Table 63. Global Active Pharmaceutical Ingredients (API) Consumption Market Forecast by Regions Table 64. Global Active Pharmaceutical Ingredients (API) Value Forecast by Countries (2021-2025) ($ Millions) Table 65. Global Active Pharmaceutical Ingredients (API) Value Market Share Forecast by Regions Table 66. Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Type (2021-2025) (K MT) Table 67. Global Active Pharmaceutical Ingredients (API) Consumption Market Share Forecast by Type (2021-2025) Table 68. Global Active Pharmaceutical Ingredients (API) Value Forecast by Type (2021-2025) ($ Millions) Table 69. Global Active Pharmaceutical Ingredients (API) Value Market Share Forecast by Type (2021-2025) Table 70. Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Application (2021-2025) (K MT) Table 71. Global Active Pharmaceutical Ingredients (API) Consumption Market Share Forecast by Application (2021-2025) Table 72. Global Active Pharmaceutical Ingredients (API) Value Forecast by Application (2021-2025) ($ Millions) Table 73. Global Active Pharmaceutical Ingredients (API) Value Market Share Forecast by Application (2021-2025) Table 74. Teva Product Offered Table 75. Teva Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 76. Teva Main Business Table 77. Teva Latest Developments Table 78. Teva Basic Information, Company Total Revenue (in $ million), Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors Table 79. Hisun Pharmaceutical Product Offered Table 80. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 81. Hisun Pharmaceutical Main Business Table 82. Hisun Pharmaceutical Latest Developments Table 83. Hisun Pharmaceutical Basic Information, Company Total Revenue (in $ million), Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors Table 84. Mylan Product Offered Table 85. Mylan Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 86. Mylan Main Business Table 87. Mylan Latest Developments Table 88. Mylan Basic Information, Company Total Revenue (in $ million), Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors Table 89. Aurobindo Pharma Product Offered Table 90. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 91. Aurobindo Pharma Main Business Table 92. Aurobindo Pharma Latest Developments Table 93. Aurobindo Pharma Basic Information, Company Total Revenue (in $ million), Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors Table 94. Aspen Product Offered Table 95. Aspen Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 96. Aspen Main Business Table 97. Aspen Latest Developments Table 98. Aspen Basic Information, Company Total Revenue (in $ million), Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors Table 99. DSM Product Offered Table 100. DSM Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 101. DSM Main Business Table 102. DSM Latest Developments Table 103. DSM Basic Information, Company Total Revenue (in $ million), Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors Table 104. Pfizer Product Offered Table 105. Pfizer Basic Information, Company Total Revenue (in $ million), Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors Table 106. Pfizer Main Business Table 107. Pfizer Latest Developments Table 108. Pfizer Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 109. Novartis Product Offered Table 110. Novartis Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 111. Novartis Main Business Table 112. Novartis Latest Developments Table 113. Novartis Basic Information, Company Total Revenue (in $ million), Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors Table 114. Huahai Pharmaceutical Product Offered Table 115. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 116. Huahai Pharmaceutical Main Business Table 117. Huahai Pharmaceutical Latest Developments Table 118. Huahai Pharmaceutical Basic Information, Company Total Revenue (in $ million), Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors Table 119. BASF Product Offered Table 120. BASF Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 121. BASF Main Business Table 122. BASF Latest Developments Table 123. BASF Basic Information, Company Total Revenue (in $ million), Active Pharmaceutical Ingredients (API) Manufacturing Base, Sales Area and Its Competitors Table 124. NCPC Product Offered Table 125. NCPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 126. NCPC Main Business Table 127. NCPC Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 128. NCPC Latest Developments Table 129. Shandong Xinhua Pharmaceutical Product Offered Table 130. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 131. Shandong Xinhua Pharmaceutical Main Business Table 132. Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 133. Shandong Xinhua Pharmaceutical Latest Developments Table 134. AbbVie Product Offered Table 135. AbbVie Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 136. AbbVie Main Business Table 137. AbbVie Latest Developments Table 138. AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 139. Sun Pharmaceutical Industries Product Offered Table 140. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 141. Sun Pharmaceutical Industries Main Business Table 142. Sun Pharmaceutical Industries Latest Developments Table 143. Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 144. Zhejiang NHU Product Offered Table 145. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 146. Zhejiang NHU Main Business Table 147. Zhejiang NHU Latest Developments Table 148. Zhejiang NHU Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 149. Dr. Reddy’s Laboratories Product Offered Table 150. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 151. Dr. Reddy’s Laboratories Main Business Table 152. Dr. Reddy’s Laboratories Latest Developments Table 153. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 154. Harbin Pharmaceutical Product Offered Table 155. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 156. Harbin Pharmaceutical Main Business Table 157. Harbin Pharmaceutical Latest Developments Table 158. Harbin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 159. Bayer Product Offered Table 160. Bayer Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 161. Bayer Main Business Table 162. Bayer Latest Developments Table 163. Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 164. Zhejiang Medicine Product Offered Table 165. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 166. Zhejiang Medicine Main Business Table 167. Zhejiang Medicine Latest Developments Table 168. Zhejiang Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 169. Northeast Pharm Product Offered Table 170. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 171. Northeast Pharm Main Business Table 172. Northeast Pharm Latest Developments Table 173. Northeast Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 174. LKPC Product Offered Table 175. LKPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E) Table 176. LKPC Main Business Table 177. LKPC Latest Developments Table 178. LKPC Basic Information, Manufacturing Base, Sales Area and Its Competitors List of Figures Figure 1. Picture of Active Pharmaceutical Ingredients (API) Figure 2. Active Pharmaceutical Ingredients (API) Report Years Considered Figure 3. Market Research Methodology Figure 4. Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate 2015-2025 (K MT) Figure 5. Global Active Pharmaceutical Ingredients (API) Value Growth Rate 2015-2025 ($ Millions) Figure 6. Product Picture of Synthetic APIs Figure 7. Product Picture of Biotech APIs Figure 8. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2015-2020) Figure 9. Global Active Pharmaceutical Ingredients (API) Value Market Share by Type (2015-2020) Figure 10. Active Pharmaceutical Ingredients (API) Consumed in CNS Figure 11. Global Active Pharmaceutical Ingredients (API) Market: CNS (2015-2020) (K MT) Figure 12. Global Active Pharmaceutical Ingredients (API) Market: CNS (2015-2020) ($ Millions) Figure 13. Active Pharmaceutical Ingredients (API) Consumed in Cardiovascular Figure 14. Global Active Pharmaceutical Ingredients (API) Market: Cardiovascular (2015-2020) (K MT) Figure 15. Global Active Pharmaceutical Ingredients (API) Market: Cardiovascular (2015-2020) ($ Millions) Figure 16. Active Pharmaceutical Ingredients (API) Consumed in Genitourinary/Hormonal Drugs Figure 17. Global Active Pharmaceutical Ingredients (API) Market: Genitourinary/Hormonal Drugs (2015-2020) (K MT) Figure 18. Global Active Pharmaceutical Ingredients (API) Market: Genitourinary/Hormonal Drugs (2015-2020) ($ Millions) Figure 19. Active Pharmaceutical Ingredients (API) Consumed in Respiratory Figure 20. Global Active Pharmaceutical Ingredients (API) Market: Respiratory (2015-2020) (K MT) Figure 21. Global Active Pharmaceutical Ingredients (API) Market: Respiratory (2015-2020) ($ Millions) Figure 22. Active Pharmaceutical Ingredients (API) Consumed in Rheumatology Figure 23. Global Active Pharmaceutical Ingredients (API) Market: Rheumatology (2015-2020) (K MT) Figure 24. Global Active Pharmaceutical Ingredients (API) Market: Rheumatology (2015-2020) ($ Millions) Figure 25. Active Pharmaceutical Ingredients (API) Consumed in Diabetes Figure 26. Active Pharmaceutical Ingredients (API) Consumed in Oncology Figure 27. Active Pharmaceutical Ingredients (API) Consumed in Others Figure 28. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020) Figure 29. Global Active Pharmaceutical Ingredients (API) Value Market Share by Application (2015-2020) Figure 30. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Company in 2017 Figure 31. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Company in 2019 Figure 32. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Company in 2017 Figure 33. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Company in 2019 Figure 34. Global Active Pharmaceutical Ingredients (API) Sale Price by Company in 2019 Figure 35. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Regions 2015-2020 Figure 36. Global Active Pharmaceutical Ingredients (API) Value Market Share by Regions 2015-2020 Figure 37. Americas Active Pharmaceutical Ingredients (API) Consumption 2015-2020 (K MT) Figure 38. Americas Active Pharmaceutical Ingredients (API) Value 2015-2020 ($ Millions) Figure 39. APAC Active Pharmaceutical Ingredients (API) Consumption 2015-2020 (K MT) Figure 40. APAC Active Pharmaceutical Ingredients (API) Value 2015-2020 ($ Millions) Figure 41. Europe Active Pharmaceutical Ingredients (API) Consumption 2015-2020 (K MT) Figure 42. Europe Active Pharmaceutical Ingredients (API) Value 2015-2020 ($ Millions) Figure 43. Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption 2015-2020 (K MT) Figure 44. Middle East & Africa Active Pharmaceutical Ingredients (API) Value 2015-2020 ($ Millions) Figure 45. Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2019 Figure 46. Americas Active Pharmaceutical Ingredients (API) Value Market Share by Countries in 2019 Figure 47. Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Type in 2019 Figure 48. Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Application in 2019 Figure 49. United States Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 50. United States Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 51. Canada Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 52. Canada Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 53. Mexico Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 54. Mexico Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 55. APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2019 Figure 56. APAC Active Pharmaceutical Ingredients (API) Value Market Share by Regions in 2019 Figure 57. APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Type in 2019 Figure 58. APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Application in 2019 Figure 59. China Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 60. China Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 61. Japan Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 62. Japan Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 63. Korea Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 64. Korea Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 65. Southeast Asia Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 66. Southeast Asia Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 67. India Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 68. India Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 69. Australia Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 70. Australia Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 71. Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2019 Figure 72. Europe Active Pharmaceutical Ingredients (API) Value Market Share by Countries in 2019 Figure 73. Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Type in 2019 Figure 74. Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Application in 2019 Figure 75. Germany Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 76. Germany Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 77. France Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 78. France Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 79. UK Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 80. UK Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 81. Italy Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 82. Italy Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 83. Russia Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 84. Russia Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 85. Spain Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 86. Spain Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 87. Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2019 Figure 88. Middle East & Africa Active Pharmaceutical Ingredients (API) Value Market Share by Countries in 2019 Figure 89. Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Type in 2019 Figure 90. Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Application in 2019 Figure 91. Egypt Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 92. Egypt Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 93. South Africa Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 94. South Africa Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 95. Israel Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 96. Israel Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 97. Turkey Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 98. Turkey Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 99. GCC Countries Active Pharmaceutical Ingredients (API) Consumption Growth 2015-2020 (K MT) Figure 100. GCC Countries Active Pharmaceutical Ingredients (API) Value Growth 2015-2020 ($ Millions) Figure 101. Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate Forecast (2021-2025) (K MT) Figure 102. Global Active Pharmaceutical Ingredients (API) Value Growth Rate Forecast (2021-2025) ($ Millions) Figure 103. Americas Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 104. Americas Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 105. APAC Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 106. APAC Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 107. Europe Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 108. Europe Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 109. Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 110. Middle East & Africa Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 111. United States Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 112. United States Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 113. Canada Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 114. Canada Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 115. Mexico Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 116. Mexico Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 117. Brazil Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 118. Brazil Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 119. China Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 120. China Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 121. Japan Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 122. Japan Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 123. Korea Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 124. Korea Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 125. Southeast Asia Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 126. Southeast Asia Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 127. India Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 128. India Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 129. Australia Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 130. Australia Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 131. Germany Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 132. Germany Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 133. France Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 134. France Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 135. UK Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 136. UK Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 137. Italy Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 138. Italy Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 139. Russia Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 140. Russia Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 141. Spain Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 142. Spain Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 143. Egypt Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 144. Egypt Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 145. South Africa Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 146. South Africa Active Pharmaceutical Ingredients (API) Value 2021-2025 ($ Millions) Figure 147. Israel Active Pharmaceutical Ingredients (API) Consumption 2021-2025 (K MT) Figure 148. Israel Active Pharmaceutical

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Chemicals and Advanced Materials Reports

Pump in Lubrication Application Market Research Report 2025

Lubrication systems use pumps for directing lubricants from the reservoir to all the lubrication points of the machine. Rapid growth of automotive and construction industries is boosting the adoption of these systems. Lubricating pumps aid in extendi...

Infrared Reflective Glazing Market Share | Industry Growth Report 2025

As per credible projections, infrared reflective glazing industry is presumed to expand with 9.7% CAGR through 2025, hence exceeding USD 2703 million by the end of study duration. Changing climatic conditions along with rising concerns regarding incr...

Sodium Isobutyl Xanthate Market Size | Industry Report, 2020-2025

According to trusted estimates, global sodium isobutyl xanthate industry is expected to witness a strong growth rate during 2019-2025. Increasing mining and extraction activities across the globe is driving the sodium isobutyl xanthate market. Use of...

Nylon Filter Market Share 2020-2025 | Growth Forecasts Report

As per credible estimates, the global nylon filter market was worth USD 178.8 million in the year 2019 and is expected to grow with a CAGR of 2.9% during 2020-2025, hence reaching USD 200.8 million by the year 2025. Increasing awareness pertaining to...

Biocomponent Fiber Market Size | Global Industry Growth Report, 2025

According to credible estimates, the biocomponent fiber market was worth USD 2913.3 million in the year 2019 and is expected to grow with a CAGR of 5.6% during the forecast period, subsequently reaching USD 3623 million by the year 2025. Growing dema...

Other Reports by LP Information Inc

Global Space Planning Software Market Growth (Status and Outlook) 2020-2025

According to this study, over the next five years the Space Planning Software market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents ...

Global Ground Penetrating Radar Software Market Growth (Status and Outlook) 2020-2025

According to this study, over the next five years the Ground Penetrating Radar Software market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report...

Global Proximity Sensing Software Market Growth (Status and Outlook) 2020-2025

According to this study, over the next five years the Proximity Sensing Software market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presen...

Global DC Servo Drives Market Growth 2020-2025

According to this study, over the next five years the DC Servo Drives market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the glob...

Global Motor Control Software Market Growth (Status and Outlook) 2020-2025

According to this study, over the next five years the Motor Control Software market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents t...

Publisher: LP Information Inc